CAIAFFA, MARIA FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 3.650
EU - Europa 3.468
AS - Asia 1.281
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 8
AF - Africa 2
OC - Oceania 2
Totale 8.421
Nazione #
US - Stati Uniti d'America 3.636
IE - Irlanda 1.089
CN - Cina 919
UA - Ucraina 769
SE - Svezia 556
IT - Italia 454
FR - Francia 186
TR - Turchia 152
FI - Finlandia 120
IN - India 101
GB - Regno Unito 95
DE - Germania 63
BE - Belgio 48
SG - Singapore 41
VN - Vietnam 40
CZ - Repubblica Ceca 28
CA - Canada 14
IR - Iran 12
RO - Romania 12
RU - Federazione Russa 12
EU - Europa 10
NL - Olanda 7
RS - Serbia 6
GR - Grecia 5
TH - Thailandia 4
AT - Austria 3
BR - Brasile 3
CL - Cile 3
ES - Italia 3
JO - Giordania 3
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
HK - Hong Kong 2
MT - Malta 2
PT - Portogallo 2
BD - Bangladesh 1
CI - Costa d'Avorio 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PL - Polonia 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
Totale 8.421
Città #
Dublin 1.089
Chandler 588
Jacksonville 539
Dearborn 455
Nyköping 331
Nanjing 276
Ashburn 205
Wilmington 175
Beijing 137
Princeton 122
Nanchang 102
San Mateo 102
Ann Arbor 99
Woodbridge 72
Shenyang 70
Boardman 67
Des Moines 64
New York 57
Foggia 54
Brussels 47
Hebei 43
Tianjin 42
Kunming 41
Jiaxing 39
Dong Ket 38
Helsinki 33
Bari 31
Pune 29
Changsha 26
Rome 26
Jinan 24
Seattle 24
Singapore 23
Hangzhou 20
Brno 19
Auburn Hills 17
Ningbo 15
Changchun 14
Stevenage 13
Zhengzhou 13
Augusta 12
London 12
Los Angeles 12
Washington 12
Hilden 11
Taizhou 11
Bologna 9
Hefei 9
Lanzhou 9
Olomouc 9
Toronto 9
Orange 8
Philadelphia 8
Guangzhou 7
Redwood City 7
Timisoara 7
Leawood 6
Shanghai 6
Ardabil 5
Chicago 5
Milan 5
Saint Petersburg 5
Bangkok 4
Capua 4
Catania 4
Florence 4
Hanover 4
Houston 4
Manfredonia 4
Munich 4
San Marzano Di San Giuseppe 4
Turin 4
Walnut 4
West Jordan 4
Bellante 3
Borås 3
Jesi 3
Kozani 3
Mola Di Bari 3
Naples 3
Napoli 3
Nettuno 3
Norwalk 3
Padova 3
Phoenix 3
Racale 3
Reggio Calabria 3
Serramazzoni 3
Alghero 2
Amsterdam 2
Belford Roxo 2
Belgrade 2
Bollate 2
Botosani 2
Bracknell 2
Campobasso 2
Cascais 2
Cedar Knolls 2
Cerignola 2
Cisternino 2
Totale 5.479
Nome #
Il fenetil estere dell'acido caffeico è un potente inibitore della via metabolica 5-lipossigenasica/leucotrienica 195
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 188
Sviluppo ed applicazione di un protocollo di desensibilizzazione rapida per Rituximab 159
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia crociata a fico e gelsi 128
Terapia con Omalizumab nell'asma severo persistente: presentazione di un caso clinico 112
Fusaproliferin production by Fusarium subglutinans and toxicity to Artemia salina, SF-9 insect cells and IARC/LCL 171 human B-lymphocytes. 107
Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever. 107
"Metodo diagnostico in vitro per allergia respiratoria da polline di Cupressus arizonica". 105
Allergy to artichoke: a case report. 103
5-lipoxygenase upregulation by dexamethasone in human mast cells. 103
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia al carciofo 100
Terapia con Omalizumab: valutazione di efficacia e tollerabilità in una casistica di 21 soggetti con asma severo non controllato 100
Allergia alimentare a Leguminose della dieta mediterranea: Phaseoulus vulgaris (fagiolo) e Pisum Sativum (pisello) 97
Apoptosis induced by the Fusarium mycotoxin beauvericin in mammalian cells. 96
Sviluppo ed applicazione di una procedura di monitoring dell'asma persistente basato su registrazione di sintomi e PEF 96
Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evedence for a noncopetitive mode of action 95
Tako-tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 95
Olive pollen allergy in Bari, Italy. 94
Flaws and improvement in skin testing in Hymenoptera venom allergy. 93
Allergia alimentare da finocchio (Phoeniculum Vulgare) ed altre Apiaceae 93
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet 92
General adverse reaction to aspirin administered by transdermal iontophoresis. 91
Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term 90
Development and application of an improved sympton score and PEF card-based procedure in the management of persistent asthma 89
Biosensori cellulari nella valutazione di nuovi detergenti ecosostenibili. 88
Grape anaphylaxis 87
Cyclooxygenase-2 expression in oral squamous cell carcinoma 85
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy. 85
EFFETTI DEL MONTELUKAST SULLA BIOSINTESI DEI LEUCOTRIENI E SULL'ATTIVITA' ENZIMATICA DELLA 5-LO 84
Wasp immunotherapy induces a long term and IgG4-independent protection. 84
Omalizumab in severe allergic asthma: efficacy assessment by comparison of pre- and post-therapy symptom score and peak espiratory flow (PEF) values. 83
Changes in skin reactivity, specific IgE and IgG levels after 1 year of immunotherapy in olive pollinosis. 83
Beauvericin cytotoxicity to the invertebrate cell line SF-9. 80
Five-lipoxygenase/leukotreiene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-infiammatory properties. 79
Significativo declino dei valori di IgE specifiche legate, evidenziato da skin prick tests quantitativi, in pazienti con asma severo trattati con omalizumab 79
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen 78
Allergeni alimentari emergenti della dieta mediterranea 78
Allergens of Arizona cypress (Cupressus arizonica) pollen: characterization of the pollen extract and identification of the allergenic components. 77
Nuove acquisizioni sul meccanismo di azione dei corticosteroidi. 77
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet. 77
Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast 76
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: PRESENTAZIONE DI UN CASO CLINICO 76
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: VALUTAZIONE DI EFFICACIA E TOLLERABILITA' IN UNA CASISTICA DI TRENTA PAZIENTI 76
Therapy with omalizumab: evaluation of effectiveness and safety in 27 patients with severe uncontrolled asthma. 75
A new subcutaneous protocol for persistent desensitisation to Rituximab. 75
Allergy to pomegranate and artichoke, novel food allergens of the mediterranean diet. 75
Italian real-life experience of omalizumab. 74
Fennel (Foeniculum vulgare); a major allergen of the Mediterranean diet 74
Monitoring of atmospheric conditions and forecast of olive pollen season. 73
Allergia alimentare da finocchio (Phoeniculum vulgare) ed altre Apiaceae 73
Novel inibitory effect on 5-lipoxygenase by the anti-asthma drug montelukast 72
Airborne Cupressaceae pollen in Southern Italy 72
Purification and fine characterization of the major allergen from Olea europaea pollen extract. 72
Five-lipoxygenase/leukotriene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-inflammatory properties. 72
Skin testing technique and precision in stinging insect allergy 70
Fig and mulberry cross-allergy 70
Flaws and improvements in skin testing in hymenoptera venom allergy 70
Retrospective monitoring in the management of persistent asthma 70
Omalizumab e monitoraggio retrospettivo dei sintomi e del PEF nell'asma severo non controllato 69
Skin testing technique and precision in stinging insect allergy 68
Cyclooxygenase-2 expression in oral squamous cell carcinoma. 68
Tako-Tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 68
Systemic adverse reaction to diclofenac administered by transdermal iontophoresis. 66
Punti di debolezza ed ottimizzazione dei tests cutanei nell'allergia a veleno di imenotteri 66
Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin. 65
Indirect food contact in severe fish allergy. 65
Novel food allergens of the Mediterranean diet. 65
Omalizumab and retrospective syntom score and PEF monitoring in severe asthma 64
Leukotriene biosyntesis inhibition and direct 5-lipoxygenase non competitive inhibition by the Cys-LT1 receptor antagonists montelukast ans zafirlukast. 64
Management dell'anafilassi da alimenti 64
Food Allergy in Southern Italy. Allergy to cynara scolymus 63
Impact of Omalizumab in 21 patients with severe asthma 63
Tests cutanei nel monitoraggio dell'immunoterapia a veleno di imenotteri 63
Efficacia e tollerabilità di Omalizumab (Xolair) dopo due anni di trattamento: studio in 17 soggetti con asma severo 63
Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak espiratory flow values before and after therapy. J Investig Allergol Clin Immunol; 62
Fennel (Foeniculum vulgare) allergy. Nico A, Vacca M, Bellotti A, Di Giacomo M, Giliberti A, Lotti A, Caiaffa MF, Macchia L. 62
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 62
Dermanyssus gallinae in città: serve un approccio multiattoriale in cui il veterinario è decisivo 62
Leukotriene biosynthesis inhibition and direct 5-lipoxygenase (5-LO) noncompetitive inhibition by the cys-LT1 receptor antagonist montelukast. 61
Terapia dell'asma severo con anticorpo monoclonale anti-IgE. Significativo declino dei valori di IgE specifiche legate, evidenziato da Skin Prick Tests Quantitativi. 60
Desensitization in Iron Product Allergy 60
Italian real-life experience of omalizumab 59
Studi "in vivo" sulla cross-reattività allergenica tra polline di Compositae anemofile e Compositae edibili 58
L'orticaria (da un punto di vista allergologico) 57
Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera) 57
Il ruolo organizzativo e pedagogico del Presidente di Corso di Laurea Magistrale in Medicina. 56
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis. A systematic review and meta-analysis. 56
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 56
The lymphocyte proliferation test (LTP) in the diagnosis of critical cases of delayed drug allergy. 55
Cost-effectiveness of grass pollen allergen immunotherapy in adults 54
Purification and fine characterization of the major allergen from Olea Europaea pollen extract. 53
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and Cypress pollen 53
Retrospective monitoring in the management of persistent asthma. 53
Immunological characterization of onion (Allium cepa) allergy 53
Omalizumab in long-term treatment of refractory chronic spontaneous urticaria: effects of discontinuation. 51
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 51
When there is no communication between urban planners and public health operators: urban Dermanyssus gallinae infestations in humans 50
Inibizione della via metabolica 5-lipossigenasica/leucotrienica da parte di sostanze antiossidanti di origine naturale 50
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 50
Characteristics and treatment regimens across ERS SHARP severe asthma registries 49
Totale 7.741
Categoria #
all - tutte 38.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.895 399 263 80 46 216 275 246 24 142 26 143 35
2020/20211.087 141 13 123 6 122 66 149 71 172 162 12 50
2021/2022715 102 1 7 23 62 21 26 53 98 70 33 219
2022/20232.690 242 114 121 161 148 247 47 203 1.249 39 59 60
2023/2024620 78 19 28 17 58 227 16 68 1 15 12 81
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 8.629